» Articles » PMID: 35601654

Antimicrobial Resistance As a Global Health Threat: The Need to Learn Lessons from the COVID-19 Pandemic

Overview
Journal Glob Policy
Date 2022 May 23
PMID 35601654
Authors
Affiliations
Soon will be listed here.
Abstract

The global COVID-19 pandemic has exacerbated existing health, social, and economic challenges and threatened progress towards achieving the UN sustainable development goals. We discuss lessons learned from the COVID-19 pandemic for global policymaking for health security governance, with a particular focus on antimicrobial resistance. We identify One Health as the primary foundation of public health risk management owing to the collaborative, multidisciplinary, and multisectoral efforts that underpin the One Health approach and that enhance understanding of the complex interactions at the human-animal-environment interface. We discuss the narrow human-centric focus of the One Health approach, highlight the underrepresentation of the environmental sector in One Health networks, and encourage greater representation from the environmental sector. Furthermore, we highlight the importance of the social sciences for health security research and the need for effective communication and trust. Finally, we underscore the importance of strengthened and collaborative health, social care, and disaster management systems. The application of these lessons will facilitate holistic, multisectoral, collaborative, and ethical actions on antimicrobial resistance.

Citing Articles

One Earth-One Health (OE-OH): Antibacterial Effects of Plant Flavonoids in Combination with Clinical Antibiotics with Various Mechanisms.

Yuan G, Lian F, Yan Y, Wang Y, Zhang L, Zhu J Antibiotics (Basel). 2025; 14(1.

PMID: 39858294 PMC: 11761287. DOI: 10.3390/antibiotics14010008.


On-Site Inactivation for Disinfection of Antibiotic-Resistant Bacteria in Hospital Effluent by UV and UV-LED.

Azuma T, Usui M, Hasei T, Hayashi T Antibiotics (Basel). 2024; 13(8).

PMID: 39200012 PMC: 11350808. DOI: 10.3390/antibiotics13080711.


Uncovering the potentiality of quinazoline derivatives against Pseudomonas aeruginosa with antimicrobial synergy and SAR analysis.

Manhas R, Rathore A, Havelikar U, Mahajan S, Gandhi S, Mahapa A J Antibiot (Tokyo). 2024; 77(6):365-381.

PMID: 38514856 DOI: 10.1038/s41429-024-00717-3.


Towards the Future of Public Health: Roadmapping Trends and Scenarios in the Post-COVID Healthcare Era.

El-Warrak L, Nunes M, Luna G, Barbosa C, Lyra A, Argolo M Healthcare (Basel). 2023; 11(24).

PMID: 38132008 PMC: 10743190. DOI: 10.3390/healthcare11243118.


Drivers of antimicrobial resistance in layer poultry farming: Evidence from high prevalence of multidrug-resistant and enterococci in Zambia.

Mudenda S, Bumbangi F, Yamba K, Munyeme M, Malama S, Mukosha M Vet World. 2023; 16(9):1803-1814.

PMID: 37859964 PMC: 10583887. DOI: 10.14202/vetworld.2023.1803-1814.


References
1.
Yang K . Unprecedented Challenges, Familiar Paradoxes: COVID-19 and Governance in a New Normal State of Risks. Public Adm Rev. 2020; 80(4):657-664. PMC: 7283883. DOI: 10.1111/puar.13248. View

2.
Clancy C, Buehrle D, Nguyen M . PRO: The COVID-19 pandemic will result in increased antimicrobial resistance rates. JAC Antimicrob Resist. 2021; 2(3):dlaa049. PMC: 7454644. DOI: 10.1093/jacamr/dlaa049. View

3.
Johnson Sirleaf E, Clark H . Report of the Independent Panel for Pandemic Preparedness and Response: making COVID-19 the last pandemic. Lancet. 2021; 398(10295):101-103. PMC: 9751704. DOI: 10.1016/S0140-6736(21)01095-3. View

4.
Ogyu A, Chan O, Littmann J, Pang H, Lining X, Liu P . National action to combat AMR: a One-Health approach to assess policy priorities in action plans. BMJ Glob Health. 2020; 5(7). PMC: 7359186. DOI: 10.1136/bmjgh-2020-002427. View

5.
Kim J, Coble D, Salyards G, Bower J, Rinaldi W, Plauche G . Antimicrobial Use for and Resistance of Zoonotic Bacteria Recovered from Nonhuman Primates. Comp Med. 2017; 67(1):79-86. PMC: 5310628. View